Phase II clinical trial of h-R3 combined radiotherapy for locoregionally advanced nasopharyngeal carcinoma

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 26, Issue 8, 2007, Pages 874-879

  Wu, Ren Rui ^a   Wu, Shao Xiong ^a   Zhao, Chong ^a   Xie, Fang Yun ^a   Gao, Jian Ming ^a   Hu, Wei Han ^a   Gao, Yuan Hong ^a   Li, Feng Yan ^a   Cui, Tian Tian ^a   Lu, Tai Xiang ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER STAGING; CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; MALE; MEGAVOLTAGE RADIOTHERAPY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SURVIVAL RATE;

ADULT; ANTIBODIES, MONOCLONAL; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PARTICLE ACCELERATORS; RADIOTHERAPY, HIGH-ENERGY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REMISSION INDUCTION; SURVIVAL RATE;

EID: 67650666347     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)